Hong Kong · Delayed Price · Currency is HKD CStone Pharmaceuticals Statistics
Total Valuation
HKG:2616 has a market cap or net worth of HKD 9.83 billion. The enterprise value is 8.36 billion.
| Market Cap | 9.83B |
| Enterprise Value | 8.36B |
Important Dates
The last earnings date was Thursday, August 27, 2026.
| Earnings Date | Aug 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:2616 has 1.59 billion shares outstanding. The number of shares has increased by 15.16% in one year.
| Current Share Class | 1.59B |
| Shares Outstanding | 1.59B |
| Shares Change (YoY) | +15.16% |
| Shares Change (QoQ) | +4.00% |
| Owned by Insiders (%) | 1.73% |
| Owned by Institutions (%) | 18.02% |
| Float | 1.19B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 34.41 |
| PS Ratio | 20.02 |
| PB Ratio | 6.59 |
| P/TBV Ratio | 7.41 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 17.04 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.58, with a Debt / Equity ratio of 0.28.
| Current Ratio | 3.58 |
| Quick Ratio | 3.44 |
| Debt / Equity | 0.28 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -32.66 |
Financial Efficiency
Return on equity (ROE) is -52.14% and return on invested capital (ROIC) is -19.91%.
| Return on Equity (ROE) | -52.14% |
| Return on Assets (ROA) | -14.44% |
| Return on Invested Capital (ROIC) | -19.91% |
| Return on Capital Employed (ROCE) | -24.19% |
| Weighted Average Cost of Capital (WACC) | 5.68% |
| Revenue Per Employee | 4.81M |
| Profits Per Employee | -4.74M |
| Employee Count | 102 |
| Asset Turnover | 0.26 |
| Inventory Turnover | 1.68 |
Taxes
In the past 12 months, HKG:2616 has paid 15.08 million in taxes.
| Income Tax | 15.08M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -51.35% in the last 52 weeks. The beta is 0.28, so HKG:2616's price volatility has been lower than the market average.
| Beta (5Y) | 0.28 |
| 52-Week Price Change | -51.35% |
| 50-Day Moving Average | 5.31 |
| 200-Day Moving Average | 6.27 |
| Relative Strength Index (RSI) | 59.37 |
| Average Volume (20 Days) | 10,680,087 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:2616 had revenue of HKD 490.92 million and -483.84 million in losses. Loss per share was -0.32.
| Revenue | 490.92M |
| Gross Profit | 275.04M |
| Operating Income | -433.18M |
| Pretax Income | -468.76M |
| Net Income | -483.84M |
| EBITDA | -419.51M |
| EBIT | -433.18M |
| Loss Per Share | -0.32 |
Balance Sheet
The company has 1.88 billion in cash and 412.42 million in debt, with a net cash position of 1.46 billion or 0.92 per share.
| Cash & Cash Equivalents | 1.88B |
| Total Debt | 412.42M |
| Net Cash | 1.46B |
| Net Cash Per Share | 0.92 |
| Equity (Book Value) | 1.49B |
| Book Value Per Share | 0.98 |
| Working Capital | 1.50B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 13.84M |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 56.03%, with operating and profit margins of -88.24% and -98.56%.
| Gross Margin | 56.03% |
| Operating Margin | -88.24% |
| Pretax Margin | -95.49% |
| Profit Margin | -98.56% |
| EBITDA Margin | -85.45% |
| EBIT Margin | -88.24% |
| FCF Margin | n/a |
Dividends & Yields
HKG:2616 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.16% |
| Shareholder Yield | -15.16% |
| Earnings Yield | -4.92% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for HKG:2616 is 14.44, which is 138.09% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 14.44 |
| Price Target Difference | 138.09% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 52.51% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |